Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
18.87
-0.79 (-3.99%)
At close: Sep 12, 2025, 4:00 PM EDT
18.90
+0.03 (0.16%)
Pre-market: Sep 15, 2025, 7:56 AM EDT
Viridian Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$38.80
Upside
+105.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +59.02% | Aug 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $45 → $41 | Buy | Maintains | $45 → $41 | +117.33% | Aug 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | +37.82% | Aug 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $28 → $32 | Buy | Maintains | $28 → $32 | +69.63% | Aug 7, 2025 |
| Needham | Needham | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +80.23% | Aug 6, 2025 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +90.83% | May 20, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $46 → $45 | Buy | Maintains | $46 → $45 | +138.54% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $31 → $27 | Strong Buy | Maintains | $31 → $27 | +43.12% | May 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $42 → $38 | Buy | Maintains | $42 → $38 | +101.43% | May 7, 2025 |
| Needham | Needham | Strong Buy Maintains $38 → $36 | Strong Buy | Maintains | $38 → $36 | +90.83% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +80.23% | Apr 23, 2025 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +101.43% | Jan 7, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $27 | Buy → Hold | Downgrades | $27 | +43.12% | Dec 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +149.14% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +80.23% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +80.23% | Dec 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.